At a recent event was recently asked about investment outcomes for venture capitalists. I didn’t have any recent data, so I said that VCs generally expect that 1/3 of their investments will see great returns, 1/3 will see modest or no returns, and 1/3 will not be profitable. VC Fred Wilson as Union Square Ventures […]
I’ll be giving a talk on “Career Development in Biotechnology” next week in the AstraZeneca seminar series at the University of Toronto. More details are available at the MBiotech website.
Courtesy of DrugPatentWatch.com: Drug Patent Expirations in November 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration ANDRODERM Watson Labs testosterone 4,849,224 NOV 12,2007 ANDRODERM Watson Labs testosterone 4,983,395 NOV 12,2007 AVITA Mylan Bertek tretinoin 4,971,800 NOV 20,2007 COMTAN Orion entacapone 4,963,590 NOV 27,2007 ELOCON Schering mometasone […]